Mitochondrial Fidelity and Homeostasis
Mitochondrial Fidelity and Homeostasis
批准号:
10373977
负责人:
Oleh Khalimonchuk
金额:
$34.79万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-06-01 至 2024-03-31
关键词:
AddressAgeAmyotrophic Lateral SclerosisBioenergeticsBiogenesisBiologicalCardiovascular DiseasesCell SurvivalCell physiologyCellsClinicalDefectDegenerative DisorderDementiaDevelopmentDiseaseDissectionEtiologyEventFailureFoundationsGlaucomaGoalsHealthHomeostasisHumanInner mitochondrial membraneInvestigationKnowledgeMalignant NeoplasmsMediatingMitochondriaMitochondrial MatrixModelingMolecularNeuropathyOrganellesOrganismOutcomeParkinsonian DisordersPathologyPathway interactionsPhysiologicalProcessProphylactic treatmentProteinsProteomeQuality ControlRegulationResearchRoleSaccharomyces cerevisiaeSignal TransductionTherapeuticTimeVisionWorkYeastscost effective treatmenteffective therapyhearing impairmentinsightmitochondrial metabolismnovelpreservationprogramsprotein complexproteostasisrepairedspatiotemporal
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The overall vision of the proposed research program is to determine how evolutionary conserved
mitochondrial quality control modules function to maintain cell survival, and how these functions can be
manipulated to achieve clinical benefits. Research in the Khalimonchuk lab is focused on providing a better
understanding of multilayered processes that mediate mitochondrial biogenesis, function and integrity. The
general goals include: 1) thorough molecular characterization of factors involved; 2) dissection of their roles
and concerted action in relevant biological mechanisms; and 3) investigation of associated regulatory and
signaling events and their potential therapeutic relevance. To that end, this MIRA proposal focuses on a group
of fundamental mechanisms that mediate mitochondrial fidelity and preserve normal mitochondrial functions
throughout a lifecycle of a cell/organism. The mitochondria and its complex protein homeostasis (proteostasis)
network involve multiple dynamic processes and pathways that adapt to homeostatic challenges and change
over time. The multifaceted biological roles of these mechanisms are highly relevant to both normal cellular
physiology and a wide range of human disorders for which no effective therapies presently exist. Progressive
mitochondrial failure has emerged as a central causative factor of prevalent degenerative diseases such as
glaucoma, hearing loss, Parkinsonism, amyotrophic lateral sclerosis, various neuropathies, dementia,
cardiovascular disorders, and certain cancers. In spite of much research, the molecular etiology of these
pathologies remains obscure. Thus, a greater understanding of the mechanisms that mediate mitochondrial
fidelity, function, and integrity, and how failure of these mechanisms drives the above clinical manifestations, is
of central importance. Unified by an overarching topic of mitochondrial fidelity and protein homeostasis, this
research program seeks to study: 1) the mechanisms that proteolytically control/regulate protein stability,
abundance, assembly, and repair within the inner mitochondrial membrane and 2) how a delicate protein
homeostasis in the mitochondrial matrix is established and maintained. In each case, the proposed work will
focus on a group of dedicated versatile factors that mediate mitochondrial self-preservation and are highly
relevant to human health. The goal is to address unresolved questions concerning the functional roles of key
molecular factors using two lauded complementary models, the yeast Saccharomyces cerevisiae and cultured
human cells. The research will uncover novel mechanisms of regulation, dynamic integration, and concerted
spatiotemporal action that are critical for mitochondrial sub-proteomes to adjust to homeostatic insults and
physiological demands and challenges. Successful outcomes from this project will provide unprecedented
insights into the coordination of mitochondrial metabolism, bioenergetics, and proteostasis and challenge
current views on mechanisms of age-associated maladies. They may also aid in the development of new
treatment/prophylaxis strategies against degenerative diseases and related pathologies that occur with age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial Fidelity and Homeostasis
-
批准号:10597652
-
项目类别:
-
资助金额:$8.2万
-
财政年份:2019
-
负责人:Oleh Khalimonchuk
-
依托单位:
A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection
-
批准号:8818735
-
项目类别:
-
资助金额:$27.32万
-
财政年份:2014
-
负责人:Oleh Khalimonchuk
-
依托单位:
A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection
-
批准号:8920657
-
项目类别:
-
资助金额:$27.32万
-
财政年份:2014
-
负责人:Oleh Khalimonchuk
-
依托单位:
A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection
-
批准号:9277480
-
项目类别:
-
资助金额:$27.32万
-
财政年份:2014
-
负责人:Oleh Khalimonchuk
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: